1,832
Views
8
CrossRef citations to date
0
Altmetric
Original Research Article

Budget impact of antimicrobial wound dressings in the treatment of venous leg ulcers in the German outpatient care sector: a budget impact analysis

, , &
Article: 1527654 | Received 07 Jun 2018, Accepted 14 Sep 2018, Published online: 01 Nov 2018

References

  • Vowden P. Vowden K The economic impact of hard-to-heal wounds: promoting practice change to address passivity in wound management. Wounds International. 2016;7:1.
  • Dowsett C. Breaking the cycle of hard-to-heal wounds: balancing cost and care. Wounds International. 2015;6(2):17–21.
  • Ehresmann U, Gallenkemper G, Hermanns HJ, et al. Diagnostik und Therapie des Ulcus cruris venosum [Diagnosis and therapy of venous leg ulcers]. German: German Phlebology Association; 2008.
  • Rabe E, Pannier-Fischer F, Bromen K, et al. Bonn vein study by the German society of phlebology: epidemiological study to investigate the prevalence and severity of chronic venous disorders in the urban and rural residential populations. Phlebologie. 2003;32(1):1–14.
  • Neumann M, Cornu-Thénard A, Juenger M, et al. S3-Guideline for diagnostics and treatment of venous leg ulcers. European Dermatology Forum (EDF); 2014. https://www.euroderm.org/dam/jcr:45231052-c7ca-45fc-92cb-c8d9dcf792b1/S3-Guideline-on-venous-leg-ulcers-Update2014.pdf
  • Mosti G, Magliaro A, Mattaliano V, et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24(3):121–2;124–7.
  • Kammerlaender G, Locher E, Suess-Burghart A, et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:2.
  • Harding K, Gottrup F, Jawien A, et al. A prospective, multi-centre, randomised, open label, parallel, comparative study to evaluate effects of Aquacel® Ag and Urgotul®. Silver dressing on healing of chronic venous leg ulcers. Int WoundJ. 2012;9:285–11.
  • Eberlein T, Haemmerle G, Signer M, et al. Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised or locally infected wounds. J Wound Care. 2012;21:1.
  • Augustin M, Brocatti LK, Rustenbach SJ, et al. Cost-of-illness of leg ulcers in the community. Int Wound J. 2014;11:283–292.
  • Purwins S, Herberger K, Debus ES, et al. Cost-of-illness of chronic leg ulcers in Germany. Int Wound J. 2010;7(2):97–102.
  • Totty JP, Bua N, Smith GE, et al. Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review. J Wound Care. 2017;26(3):105–114.
  • German Federal Statistical Office (DESTATIS) Statistisches Jahrbuch 2017 – soziales [German Federal Statistical Office: statistical yearbook 2017]. German: Statistisches Bundesamt (DESTATIS); 2016. p. 229–258. https://www.destatis.de/DE/Publikationen/StatistischesJahrbuch/StatistischesJahrbuch2017.pdf?__blob=publicationFile
  • German Federal Statistical Office (DESTATIS) GENESIS - Gestorbene, Sterbefälle je 1000 Einwohner: deutschland, Monate [German Federal Statistical Office: GENESIS: monthly mortality rate Germany]. German: Statistisches Bundesamt (DESTATIS); 2016.
  • Köster I, Schubert I. Abschlussbericht für MedInform - Informations- und Seminarservice Medizintechnologie. Epidemiologie und Versorgung von Patienten mit chronischen Wunden. Eine Analyse auf der Basis der Versichertenstichprobe AOK Hessen/KV Hessen [MedInform final report – information and seminar Service in medical technology. Epidemiology and care of patients with chronic wounds. An Analysis based on a sample of AOK Hesse (statutory health insurance)]. German: PMV Research Group; 2015.
  • Elm E, Altman DG, Egger M, et al., STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008 Apr; 61(4):344–349.
  • Boutron I, Altman DG, Moher D, et al. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–47.
  • Munter KC, Beele H, Russel L, et al. Effect of a sustained silver-releasing dressing on ulcers with delayed healing: the CONTOP study. J Wound Care. 2013;15(5):199–206.
  • Insight Health. IH-Galaxy September 2017.
  • Lauer-Taxe. 03.January 2018.
  • Kassenärztliche Vereinigung Berlin. Arzneimittel-Richtgrößenvereinbarung nach § 84 Abs. 6 SGB V für das Jahr 2017 für Berlin [Drug benchmark agreement according to § 84 Abs. 6 SGB V for Berlin (2017)]. German: Kassenärztliche Vereinigung Berlin; 2017.
  • Kassenärztliche Vereinigung Westfalen-Lippe. Vereinbarung nach § 106b Abs. 3 Satz 3 SGB V i.V.m. § 84 Abs. 6 SGB V über fallbezogene, arztgruppenspezifische Richtgrößen für Arzneimittel und Heilmittel 2017 [Drug and remedy benchmark agreement according to § 106b Abs. 3 Satz 3 SGB V i.V.m. § 84 Abs. 6 SGB V for Westphalia-Lippe 2017]. German: Kassenärztliche Vereinigung Westfalen-Lippe; 2017.
  • Mätzler M, Kassenärztliche Vereinigung Sachsen. Richtgrößen im Jahr 2017 im Bereich der KV Sachsen [Drug and remedy benchmark agreement according to § 106b Abs. 3 Satz 3 SGB V i.V.m. § 84 Abs. 6 SGB V for Saxony 2017]. German: Kassenärztliche Vereinigung Sachsen; 2017.
  • BVmed. Erstattung von Verbandmitteln [Reimbursement of bandages]. Website. https://www.bvmed.de/de/versorgung/verbandmittel. German.
  • Yan S, Colin X, Coudray-Omnés C, et al. A budget impact analysis comparing a Hydrofiber® dressing to an alginate dressing in managing exuding venous leg ulcers in France. Int Wound J. 2014;11(3):304–313.
  • Nherera LM, Woodmansey E, Trueman P, et al. Estimating the clinical outcomes and cost differences between standard care with and without Cadexomer Iodine in the management of chronic venous leg ulcers using a Markov model. Ostomy Wound Management. 2016;62(6):26–40.
  • Guest JF, Fuller GW. Vowden P Venous leg ulcer management in clinical practice in the UK: costs and outcomes. Int Wound J. 2018;15(1):29–37.
  • Caro JJ, Briggs AH, Siebert U, et al. ISPOR Task Force Reports: modelling good research practices – overview: A report of the ISPOR-SMDM modelling good research practices task force-1. Value in Health. 2012;15:796–803.
  • Drummond M. Experimental versus observational data in the economic evaluation of pharmaceuticals. Med Decis Making. 1998;18(2):p12–8.
  • Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. 4th. Oxford: Oxford University Press; 2015.
  • International consensus. Appropriate use of silver dressings in wounds. An expert working group consensus. London: Wounds International; 2012.
  • Michaels JA, Campbell WB, King BM, et al. A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial. Health Technol Assess (Rockv). 2009;13:56.
  • Sozialgesetzbuch (SGB) Fünftes Buch (V) - Gesetzliche Krankenversicherung - (Artikel 1 des Gesetzes v. 20. Dezember 1988, BGBl. I S. 2477) [German Social Security Statute Book V: Statutory health insurance]. German.